Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial
Objective To compared the cost-effectiveness of coadministration of a probiotic adjuvant with peanut oral immunotherapy (PPOIT) with placebo (no treatment) in children with peanut allergy.Design Prospectively planned cost-effectiveness analysis alongside a randomised control trial.Setting The Royal...
Saved in:
| Main Authors: | Li Huang, Mimi Tang, Kim Dalziel, Melanie Lloyd, Paxton Loke, Adriana C Lozinsky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/12/e075521.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy
by: Edoardo Cavaglià, et al.
Published: (2025-04-01) -
Use of Probiotics to Control Aflatoxin Production in Peanut Grains
by: Juliana Fonseca Moreira da Silva, et al.
Published: (2015-01-01) -
Peanut Allergy Diagnosis: Current Practices, Emerging Technologies, and Future Directions
by: Travis Satnarine, et al.
Published: (2025-02-01) -
Development of Transient Peanut Allergy Following Lung Transplantation: A Case Report
by: Sacha Bhinder, et al.
Published: (2011-01-01) -
Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study
by: Victoria Landry, et al.
Published: (2024-10-01)